Peptide growth factors in the prostate as mediators of stromal epithelial interaction

British Journal of Urology

Volumn 77, Issue 5, 1996, Pages 627-633

  Byrne, R L ^a,b,c   Leung, H ^a   Neal, D E ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c Addenbrooke s Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ANDROGEN; BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR; MESSENGER RNA; PEPTIDE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA1;

CELL DIFFERENTIATION; CELL GROWTH; HUMAN; MEDIATOR; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; REVIEW; STROMA;

EID: 0030418270     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410x.1996.09721.x     Document Type: Review

References (65)

1. Assoian RK. Komoriya A. Meyers CA. Miller UM. Sporn MB. Transforming growth factor beta in human platlets: Identification of a major storage site, purilicalion and characterization. J Biol Chem 1983: 258: 71 55-60
2. Folik ÇA. Dïirl LL. Meyers CA. Smith DM. Sporn MB. Purilicalion and initial characterisation of a type beta transforming growth factor from human placenta. Proc Natl Acad Sei USA 1983; 80: 3676-80
3. Massagué J. Type beta transforming growth factor from feline sarcoma virus-transformed rat cells. Isolation and biological properties. J Biol Chcm 1984: 259: 9756-61
4. Kyprianou N. Isaacs J. Identification of a cellular receptor for transforming growth factor beta in rat ventral prostate and its negative regulation by androgens. i'ndocrin 1988; 123: 2124-21 31
5. Wilding G, Xugmeier (ï. Knabbe C, Flanders K. Gelmann E. Differential effects of transforming growth factor beta on human prostate cancer cells in vitro. Mol Cell End 1989: 62: 79-87
6. Sutkowski DM. Chan-Jye F. Sensibar J et ni. Interaction of epidermal growth factor and TGF-β in human prostatic epithelial cells in culture. 1'rmtnle 1992: 21: 1 33-143
7. Story M'F. Hopp K, Meier DA. Begun FP. Lawson RK. Influence of transforming growth factor BI and other growth factors on basic fibroblast growth factor level and proliferation of cultured human-derived libroblasts. Prostate 1993: 22: 183-f97
8. Laiho M. De Caprio JA. Ludlovv JW. I.ivingstone DM. Massagué J. Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 1990; 62: 175-85
9. Zentella A, Weiss F. Ralph DA. Laiho M, Massagué J. Early gene responses to transforming growth factor βin cells lacking growth-suppressive RB function. Mol Cell Rial 1991; 11: 4952-8
10. Troung LD. Kadmon D, McCune BK, Flanders KC. Scardino PT, Thompson TC. Association of transforming growth factor with prostate cancer. Human Pathology 1993; 24: 4-9
11. Zhou ZZ, Barrack E. Transforming growth factor-βl (TGF-βl) expression in prostate cancer. J Urol 1994: 151: 366A
12. Shain S, Lin A. Koger JD, Karaganis AG. Rat prostate cancer cells contain functional receptors for transforming growth factor β. Endocrin 1990: 126: 818-25
13. Steiner MS. Barrack E. Transforming growth factor βl over-production in prostate cancer: effects on growth in vivo and in vitro. Molec Endocrin 1992: 6: 15-25
14. Ignotz RA. Massagué J. Transforming growth factor-β stimulates the expression of flbronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 1986: 261: 4337-45
15. Kehrl JH. Wakefield LM. Roberts AB et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163: 1037-50
16. Torre-Amione G. Beauchamp RD, Koeppen H et al. A highly immunogenic tumour transfected with a murine transforming growth factor-beta 1 cDNA escapes immune surveillance. Proc Nat Acad Sei USA 1990: 87: 1486-90
17. Yang EY, Moses H. Transforming growth factor B1- induced changes in cell migration, proliferation and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990: 111: 731-41
18. McKeenan WL, Adams P, Rosser MP. Direct mitogenic effects of insulin, epidermal growth factor, glucocorticoid. cholera toxin, unknown pituitary factors and possibly prolactin. but not androgen. on normal rat prostate epithelial cells in serum-free primary culture. Cancer Res 1984: 44: 1998-2010
19. Hiaramatsu M, Kashimata M., Minami N, Sato A. Murayama M. Androgenic regulation of epidermal growth factor in the mouse ventral prostate. Biochem Int 1988; 17: 311-7
20. Derynck R. The physiology of transforming growth factor -α. Adv Cancer Res 1992; 58: 27-52
21. Winkler ME, O'Conner L, Winget M. Fendly B. Epidermal growth factor and transforming growth factor α bind differently to the epidermal growth factor receptor. Biochem 1989; 28: 6373-8
22. Derynck R, Goeddel D, Ullrich A et al. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumours. Cancer Res 1987: 47: 707-12
23. Downward J, Yarden Y, Mayes E et al. Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature 1984: 307: 521-7
24. Todaro GJ, Fryling C, DeLarco JE. Transforming growth factors produced by certain human tumour cells : polypeptides that interact with epidermal growth factor receptors. Prof Nat Acad Sei USA 1980: 77: 5258-62
25. Mydlo JH. Michaeli J. Cordon Cardo C, Goldenberg AS. Heston WD. Fair WR. Expression of transforming growth factor alpha and epidermal growth factor receptor messenger RNA in neoplastic and non-neoplastic human kidney tissue. Cancer Res 1989: 49: 3407-11
26. Bennett C. Paterson I. Corishley CM, Luqmani YA. Expression of growth factor and epidermal growth factor receptor encoded transcripts in human gastric tissues. Cancer Res 1989: 49: 2104-11
27. King CR, Draus MH. Aaronson SA. Amplification of a novel v-erbB related gene in a human mammary carcinoma. Science 1985: 229: 974-6
28. Fukushige SI. Matsubara Kl. Yoshida M et al. Localisation of a novel v-erbB related gene c-erbE2 on human chromosome 17 and its amplification in a gastric cancer cell line. Moi Cell Biol 1986; 6: 955-8
29. Shaikh N. Lai L, McLoughlin J, Clark D. Williams G. Quantative analysis of epidermal growth factor in human benign prostatic hyperplasia and prostatic carcinoma and its prognostic significance. Anticancer Research 1990: 10: 873-4
30. Morris GL. Dodd JG. Epidermal growth factor receptor mRNA levels in human prostatic tumours and cell lines. J Urol 1990: 143: 1272-4
31. Ching KZ. Ramsey E. Pettigrew N. Cunha RD. Jason M, Dodd JG. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mo) Cell Biochem 1993: 126: 151-8
32. MacDonald A. Chisholm G, Habib FK. Production and response of a human prostate cancer line to transforming growth factor-like molecules. BrJ Cancer 1990: 62: 579-84
33. Connolly JM. Rose D. Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate 1989: 15: 177-86
34. Connolly JM, Rose D. Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 1990: 16: 209-18
35. Mellon K, Thompson S. Charlton RG et al. p-53. c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol 1992; 147: 496-9
36. Ibrahim GK, Kerns B. MacDonald JA et al. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. J Urol 1993; 149: 170-3
37. Ware fL. Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer. Cancer Met Rev 1993; 12: 287-301
38. Harper ME. Goddard L, Glynne-Jones E et al. An immunocytochemical analysis of TGF-α expression in benign and malignant prostatic tumors. Prostate 1993: 23: 9-23
39. Maddy SO, Chisholm G. Busuttil A. Habib FK. Epidermal growth factor receptors in human prostate cancer: correlation with histological differentiation of the tumour. Br I Cancer 1989; 60: 41-4
40. Davies P. Eaton C. Binding of epidermal growth factor by human normal, hypertrophie and cardnomatous prostate. Prostate 1989: 14: 123-32
41. MacDonald A. Habib F. Divergent responses to epidermal growth factor in hormone sensitive and insensitive human prostate cancer cell lines. Br J (Tancer 1992: 65: 177-82
42. Holer DR. Sherwood E. Bromberg WÜ. Mendelsohn J. Lee Chung. Koxlowski JM. Autonomous growth of androgenindependent human prostatic carcinoma cells. Role of transforming growth factor-A. Cancer Res 1991: 51: 27MO-5
43. Schuurmans ALG. Bolt J, Veldscholte J. Mulder E. Regulation of growth of LNCaP human prostate tomour cells by growth factors and steroid hormones. J Steroid Hiochem Molec Biol 1991: 40: 193-7
44. Froesch KR. Schmid C, Schwander J, Zapf J. Action of insulin-like growth factors. Ann Rev Physiol 1985: 47: 443-h7
45. Stiles CD. Capone C. Scher CD. Antoniades HN, Van Wyk JJ. Pledger WJ. Dual control of cell growth by somatomedins and platlet-derived growth factor. Pror NatI Acad Sri 1979: 76: 1279-83
46. Shimasaki S. I.ing N. Identification and molecular characterisation of insulin-like growth factor binding proteins. I'wu Growth I'actor Res 1991: 3: 243-66
47. Neely FK, Beukers MW Oh Y. Cohen P. Rosenfeld RC,. Insulin-like growth factor receptors. Acta Pediatr Scand (suppl) 1991: 372: 116-23
48. Cohen P. Pec-hl D. Lamson G, Rosenfeld KG. Insulin-like growth factors (IGF's). IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin iJtdocrinol Mi-tab 1991: 73: 401-7
49. Fiorclli G. De Bellis A, Longo A et J. Insulin-like growth factor I receptors in human hyperplastic prostate tissue: Characterization, tissue localization, and their modulation by chronic treatment with a gonadotropin-releasing hormone analogue. J Clin Endocrinol Metab 1991: 72: 740-6
50. Polychronakos C. Janthly U. Lehoux JG. Koutsiliens M. Mitogenic effects of insulin and insulin-like growth factors on PA-III rat prostate adenocarcinoma cells: Characterization of the receptors involved. Prostate 1991; 19: 31 3-21
51. Cohen P. l'eehl D. Rosenfeld RG. The IGF axis in the prostate. Honn Mi-tab Rex 1994: 26: 81-4
52. Barni T. Vannelli B. Sadri R et al. Insulin like growth factor I (IGF-I) and its binding protein IGF-BP4 in human prostatic hyperplastic tissue: gene expression and its cellular location. J din Endomnol Metab 1994: 7: 778-83
53. Cohen P. Peehl D. Hintz RL, Rosenfeld RG. Insulin-like growth factor axis abnormalities in primary cultures of Hbroblasts from patients with benign prostatic hypertrophy. Clin Rex 1992; 40: 93a
54. Rotwein P. Structure, evolution, expression and regulation of insulin-like growth factors I and II. Growth Factors 1991: 5: 3-18
55. Iwamura M. Sluss PM. Casamento JB. Cockett ATK. Insulinlike growth factor I: Action and receptor characterization in human prostate cancer cell lines. Prostate 1993: 22: 243-52
56. Pietrzkowski Z. Mulholland G, Cornelia L, Hameson BA. Weinike D. Baserga R. Inhibition of growth of prostatic cancer cell lines by peptide analogues of insulin-like growth factor I. Cancer Res 1993: 53: 1102-6
57. Yee D, Paik S. Lebovic GS et al. Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer. Mol Endocrin 1989: 3: 509-17
58. Cohen P, Peehl D. Stamey TA. Wilson K. Gemmons DR. Rosenfeld RG. Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients. J Clin Endoirinol Metab 1993; 76: 830-5
59. Story MT. Polypeptide modulators of prostatic growth and development. In Cancer Surveys 1991: 11: 123-46
60. Story MT. Sasse J. Jacobs SC, Lawson RK. Prostatic growth factor: Purification and structural relationship to basic iibroblast growth factor. Biochein 1987: 26: 3843-9
61. Muller JM. Lee FS. Dickson C. Peters G. Pattengale. Leder P. The mt-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO 1990; 9: 907-13
62. Yan G. Fukabori Y, McBride G. Nikolaropolous S, McKeehan WL. Exon switching and activation of stromal and embryonic Iibroblast growth factor (FGF)- FGF receptor genes in prostate epithelial cells accompany stromal independence and malignancy. Mol Cell Biol 1993: 13: 4513-22
63. Neufeld G. Mitchell R. Ponte P. Gospodarowicz D. Expression of human basic Hbroblast growth factor cDNA in baby hamster kidney-derived cells results in autonomous cell growth. J Cell Biol 1988: 106: 1385-94
64. Nakamolo T. Chang C. Li A. Chodak GW. Basic Iibroblast growth factor in human prostate cancer cells. Cancer Res 1992: 52: 571-7
65. Culig Z, Hobisch A. Cronauer MV ft al. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor I, keratinocyte growth factor and epidermal growth factor. Cancer Res 1994; 54: 5474-8